White House to Spend Billions to Increase Virus Testing and Ease Reopening



WASHINGTON — The Biden administration, moving to address a lag in coronavirus testing that is hindering the reopening of schools and the economy, said Wednesday that it would invest $10 billion to ramp up screening of students and educators with the goal of returning to in-person learning by the end of the school year.

Congress approved the $10 billion expenditure when it passed President Biden’s $1.9 trillion stimulus package, which he signed into law last week. The Centers for Disease Control and Prevention will distribute the money to states in early April and will spend an additional $2.25 billion to expand testing in underserved communities beyond the schools, officials said.

How far those moves will go toward reopening schools and reviving the economy is unclear. Experts say the United States does not have nearly enough rapid tests to conduct the kind of routine screening the administration envisions to allow students and teachers to safely return to the classroom.

“This isn’t going to move the needle,” said Michael Mina, an immunologist and epidemiologist at Harvard, who argued that onerous Food and Drug Administration regulations were preventing new types of rapid antigen tests from being approved, worsening the coronavirus crisis.

“The states don’t just need money,” Dr. Mina said. “The states don’t just need advice from the C.D.C. The states need the test to be available.”

The moves come as coronavirus testing declines nationwide, a trend deeply concerning to public health experts. Some states have converted mass testing sites to mass vaccination centers, and their overtaxed health departments do not have the bandwidth to do both.

Between Feb. 1 and March 15, as the infection rate dropped and Americans focused on getting vaccinated, the average number of coronavirus tests being conducted daily dropped 24 percent, according to statistics maintained by Johns Hopkins University.

Jennifer B. Nuzzo, a Johns Hopkins epidemiologist who wrote about the decline in an opinion piece in The New York Times, said in an interview that aggressive testing remained vital to ending the pandemic, especially as more contagious coronavirus variants emerged and states relaxed their lockdown measures. She said the Biden administration needed to move quickly on testing to make a difference.

“I understand why states are focusing on vaccines,” Dr. Nuzzo said. “It’s very important that we prioritize the rollout of vaccines, but not at the complete expense of testing.”

Experts including Dr. Nuzzo and Dr. Mina say the United States has never fully deployed testing as an effective tool for tracking and containing the virus. The Biden administration’s new initiatives are an attempt to do that by testing asymptomatic people — particularly students, teachers and school staff — to detect outbreaks before they explode, as opposed to simply testing those with symptoms to determine if they are infected.

Reopening schools has been one of Mr. Biden’s top priorities — and one of the most contentious issues facing the administration. With millions of American children still confined to virtual learning, education experts say that many are suffering, psychologically as well as academically.

Even so, many schools are already operating at least partially in person, and evidence suggests they are doing so relatively safely. Research shows in-school spread can be mitigated with simple safety measures like masking, distancing, hand-washing and opening windows.

Mr. Biden’s education secretary, Miguel A. Cardona, said Wednesday that the department would have a “national reopening summit for schools” next week, and would outline “best practices from across the country on how to do this safely and how to do it quickly.”

>

Mr. Biden, who initially called for all schools to reopen within 100 days of his inauguration, later narrowed that goal to elementary and middle schools, and has set the reopening benchmark at “the majority of schools,” or 51 percent. But there are still many hurdles, including convincing teachers’ unions that policies are in place to ensure a safe return and easing the fears and frustrations of parents.

One stumbling block to reopening has been the C.D.C.’s recommendation that people remain six feet apart if they do not live in the same household. Amid a growing understanding of how the virus spreads, some public health experts are calling on the agency to reduce the recommended distance from six feet to three.

Dr. Anthony S. Fauci, Mr. Biden’s senior medical adviser for the pandemic, and Dr. Rochelle Walensky, the C.D.C. director, have said the guidance for social distancing in schools is under review.

The administration said Wednesday that the C.D.C. and state and local health departments would help states and schools put testing programs in place. The C.D.C. also updated its guidance on which types of tests should be used in different settings, such as schools, prisons or nursing homes.

The new guidance provides more information about different kinds of tests, including how to choose among them and interpret the results. The agency recommends that people who have Covid-19 symptoms or who may have been exposed to someone with the disease take a diagnostic test.

These tests include polymerase chain reaction, or P.C.R., tests, which can detect very small traces of viral DNA but typically need to be processed in a laboratory, and antigen tests, which are less sensitive but generally cheaper and faster.

Antigen tests may be especially useful for screening large numbers of people — in schools or workplaces, for instance — who do not have symptoms. However, their lower sensitivity means that follow-up laboratory testing may be required, the C.D.C. guidance notes.

In apparent anticipation of Wednesday’s announcement, the F.D.A. said on Tuesday that it was providing new recommendations and information for test developers to “streamline” the path to emergency approval for screening tests.

>

But Dr. Mina said the new guidelines do not address what he regards as a fundamental problem: The F.D.A. is holding up the approval of new rapid antigen tests, including at-home tests, by incorrectly measuring them against the more sensitive P.C.R. tests. Dr. Mina said the two are not comparable. While rapid tests are available, their production has fallen far behind the need. Currently, just three at-home tests have F.D.A. authorization.

“The requirements of the F.D.A. have not kept up with the science,” he said. “They are living in this archaic world where P.C.R. is the only test and the only metric, and literally requiring antigen test after antigen test to be buried in purgatory.”

He also noted that federal guidelines do not address another hurdle schools are facing: the requirement that they obtain certification under the Clinical Laboratory Improvement Amendments, or CLIA, a set of 1988 regulations that impose restrictions on who can administer laboratory tests.

Dr. Walensky said Wednesday that, while some states have found creative ways around the requirement, “there continues to be more work to do” to address the issue.

The $2.25 billion for testing in underserved populations is intended to address the racial disparities laid bare by the pandemic. Black and Latino people are far more likely than white people to get infected with the coronavirus and to die from Covid-19, and those disparities extend to testing, experts say. The vaccination rate for Black people in the United States is half that of white people, and the gap for Hispanic people is even larger, according to a Times analysis of state-reported race and ethnicity information.

The money will be given in grants to public health agencies to improve their ability to test for and track the virus.

Dr. Marcella Nunez-Smith, who leads Mr. Biden’s Covid-19 equity task force, told reporters that the administration was also working on getting therapy treatments, including monoclonal antibody therapies, to underserved communities through a $150 million grant.

“For those individuals who get Covid-19, we want to make sure that they too have the benefit of the latest in scientific discovery,” she said, “to help them hope and help them toward a safe and speedy recovery.”

Emily Anthes contributed reporting from New York.